Priyanka Ghosh
Internal Medicine · Pittsburgh, PANPI 1164954483
Payments from drug & device makers
Across 217 payments — averaging $61.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Boston Scientific$2K
- Edwards Lifesciences$2K
- W. L. Gore & Associates, Inc.$2K
- Abbott$1K
- Abiomed$853
- plus $3K from 29 others
Across 1 payment — averaging $820.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$820
What the payments were for
- Consulting fees$1481%
- Grants$1,0638%
- Travel & lodging$3,09823%
- Food & beverage$8,50464%
- Education$5634%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 33 | $2,531 |
| Boston Scientific | 13 | $2,202 |
| Edwards Lifesciences | 19 | $2,188 |
| W. L. Gore & Associates, Inc. | 25 | $1,891 |
| Abbott | 37 | $1,210 |
| Abiomed | 19 | $853 |
| Novartis | 17 | $298 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $278 |
| Teleflex LLC | 3 | $267 |
| Inari Medical, Inc. | 2 | $236 |
| Asahi Intecc USA, Inc. | 1 | $196 |
| Jenavalve Technology, Inc. | 1 | $148 |
| Pfizer | 7 | $122 |
| Ferring Pharmaceuticals Inc. | 1 | $121 |
| Amgen | 5 | $110 |
| Tactile Systems Technology Inc | 1 | $103 |
| Chiesi USA, Inc. | 1 | $70 |
| AstraZeneca | 4 | $66 |
| Stryker | 1 | $60 |
| BD | 1 | $50 |
| Philips North America LLC | 2 | $49 |
| Cardiva Medical, Inc. | 2 | $40 |
| Boehringer Ingelheim | 2 | $38 |
| Actelion Pharmaceuticals US, Inc. | 2 | $37 |
| Johnson & Johnson | 2 | $33 |
| Heartflow, Inc. | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
| Bayer | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $20 |
| Merck | 1 | $20 |
| Terumo Medical Corporation | 1 | $19 |
| Lantheus Medical Imaging, Inc. | 1 | $17 |
| Scilex Pharmaceuticals Inc. | 1 | $15 |
| Endotronix, Inc. | 1 | $13 |
| Novo Nordisk | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$1,455
- GORE CARDIOFORM Septal Occluder$1,100
- SAPIEN 3 Ultra RESILIA$530
- Impella$379
- GORE CARDIOFORM ASD Occluder$352
- ONYX FRONTIER$322
- AVVIGO Guidance System$298
- Edwards SAPIEN 3 Transcatheter Heart Valve$236
- EnSite Precision Cardiac Mapping System$208
- PERIPHERAL VASCULAR$196
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$182
- COROFLOW$169
- Diamondback Coronary$162
- FLOWTRIEVER CATHETER, S$145
- CT THROMBECTOMY SYSTEM KIT$145
- TURNPIKE$144
- OPTICROSS$135
- ENSITE$133
- AMPLATZER AMULET$129
- SPACEOAR VUE$122
How this compares
$13,377 in reported general payments places this provider in the 95th percentile of 5,705 internal medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 30 | $33,520 |
| EliquisApixaban | 25 | $27,762 |
| JardianceEmpagliflozin | 17 | $14,369 |
| BrilintaTicagrelor | 23 | $11,857 |
| Metoprolol Succinate | 64 | $1,016 |
| Carvedilol | 42 | $636 |
| Atorvastatin Calcium | 52 | $560 |
| Spironolactone | 66 | $339 |
| ClopidogrelClopidogrel Bisulfate | 17 | $291 |
| Nadolol | 11 | $259 |
| Torsemide | 15 | $228 |
| Valsartan | 27 | $212 |
| Rosuvastatin Calcium | 22 | $155 |
| Losartan Potassium | 14 | $136 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $298 | $33,52030 claims |
| PfizerEliquis | $122 | $27,76225 claims |
| Boehringer IngelheimJardiance | $38 | $14,36917 claims |
| AstraZenecaBrilinta | $66 | $11,85723 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,705 internal medicine providers in Pennsylvania.
Other internal medicine in Pittsburgh
- Siddharth ShethPittsburgh$11M
- Liza VillaruzPittsburgh$6.6M
- Raman PurighallaPittsburgh$3.9M
- Annie ImPittsburgh$1.2M
- Manisha JhambPittsburgh$1.1M
- Enrico NovelliPittsburgh$397K
- Donald MiddletonPittsburgh$258K
- Thomas CurleyPittsburgh$213K
- Sandra SobelPittsburgh$178K
- Jonathan EpsteinPhiladelphia$13.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.